- Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): Two open-label, non-comparative, randomised, phase 2 trials. The lancet oncology. 2018 Academic Article GET IT
Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma.
Journal of Cancer Research and Clinical Oncology.
Times cited: 1
Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: A randomized clinical trial.
JAMA - Journal of the American Medical Association.
Times cited: 147